- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04445584
7 Tesla MRI Evaluation of the Spine (Asymptomatic)
October 1, 2025 updated by: Reto Sutter, MD, Balgrist University Hospital
7 Tesla MRI Evaluation of the Spine
High-resolution MRI (7 Tesla) of the cervical spine is capable to provide good differentiation between nerve and surrounding tissues within foramen und allows to reliably quantify the diameter of nerve roots/ganglia.
Secondly, detailed anatomy of vertebral artery and its relation to neural structures / foramina can be assessed.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
600
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Canton of Zurich
-
Zurich, Canton of Zurich, Switzerland, 8008
- Recruiting
- Balgrist University Hospital
-
Contact:
- Christoph Germann, MD
- Phone Number: +41443863322
- Email: christoph.germann@balgrist.ch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
asymptomatic individuals
Description
Inclusion criteria:
- Informed consent as documented by signature (Appendix Informed Consent Form)
- >18 years old
- Patients presenting chronic back pain (> 2 months) without recent trauma, previous MRI (1,5 or 3T) for clinicals indications or asymptomatic individuals (for depicting normal microanatomy)
Exclusion criteria:
- previous surgery
- tumor patients
- pregnancy or breast feeding
- any MRI contra-indications
- any MRI contra-indications
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
standard values (diameter in mm) of nerve roots/ganglia/neuroforamen in each segment
Time Frame: 1 year
|
measure the diameter of the neuroforamen (in mm) and the diameter of each cervical nerve root/ganglion within the neuroforamen (in mm)
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
relation of vertebral artery to neural structures - assessment of contact between ganglion/spinal nerve and vertebral artery by assessing the presence of fat tissue between these structures.
Time Frame: 1 year
|
to assess if there is contact between the vertebral artery and the ganglion/spinal nerve at each segment and each side if no fat tissue is interposed between the ganglion and vertebral artery it is classified as having contact.
If contact is present, the length of contact (in mm) will be measured in the axial plane.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2020
Primary Completion (Actual)
February 1, 2022
Study Completion (Estimated)
September 30, 2027
Study Registration Dates
First Submitted
June 19, 2020
First Submitted That Met QC Criteria
June 23, 2020
First Posted (Actual)
June 24, 2020
Study Record Updates
Last Update Posted (Estimated)
October 2, 2025
Last Update Submitted That Met QC Criteria
October 1, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- R450
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Magnetic Resonance Imaging
-
BayerCompletedMagnetic Resonance Imaging | Magnetic Resonance AngiographyPoland, China, France, Germany, Hungary, Korea, Republic of, South Africa, Spain, Thailand, Taiwan, Czech Republic, Hong Kong, Italy, Kazakhstan, Russian Federation, Bosnia and Herzegovina, Greece, Canada, Vietnam, Kyrgyzstan
-
Centre Hospitalier Régional Metz-ThionvilleUniversity of LorraineRecruitingMagnetic Resonance ImagingFrance
-
Centre Hospitalier Universitaire, AmiensCompletedMagnetic Resonance ImagingFrance
-
Jessa HospitalCompletedMagnetic Resonance ImagingBelgium
-
BayerCompletedMagnetic Resonance ImagingUnited States, Korea, Republic of, France, Germany, Italy, Switzerland, United Kingdom
-
Boston Scientific CorporationCompletedMagnetic Resonance ImagingSpain, Hong Kong, Germany, Israel, United Kingdom, Italy, United States, Malaysia, Belgium
-
MegaPro Biomedical Co. Ltd.CompletedMagnetic Resonance ImagingTaiwan
-
BayerCompletedMagnetic Resonance ImagingJapan
-
BayerCompletedMagnetic Resonance ImagingPhilippines
-
Reto Sutter, MDRecruiting
Clinical Trials on 7 Tesla MRI
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMetastatic Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the BrainUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate... and other conditionsUnited States
-
Poitiers University HospitalWithdrawn
-
University of MinnesotaCompleted
-
Johns Hopkins UniversityWithdrawnAmyotrophic Lateral Sclerosis (ALS)United States
-
Radboud University Medical CenterUnknown
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedGlioma | Metastatic Malignant Solid Neoplasm | Central Nervous System Neoplasm | Metastatic Malignant Neoplasm in the Central Nervous SystemUnited States
-
Balgrist University HospitalRecruitingMagnetic Resonance Imaging | Cervical Spine DiseaseSwitzerland
-
CSEM Centre Suisse d'Electronique et de Microtechnique...Institute for Diagnostic and Interventional Neuroradiology, InselspitalRecruitingEpilepsy | Healthy | Psychosis | Essential TremorSwitzerland
-
Assistance Publique Hopitaux De MarseilleNot yet recruitingParkinson Disease | Progressive Supranuclear PalsyFrance